E
Endologix
Developer and manufacturer of minimally invasive treatments for aortic disorders
At a glance
- Status
- Listed
- Founded
- 1992
- Headquarters
- Santa Rosa, United States
- Listing
- IPO 1996
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Patents
58 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Endologix was the backer or acquirer, 2010–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Endologix's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Endologix's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Endologix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Endologix on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.